In this case-control study, we investigated the association between polymorphisms in cytokine/chemokine genes (TNF-A -308 G/A, RANTES-403 G/A, IL-1A -889 C/T and MCP-1 2518 G/A) and prostate cancer risk. This evidence concerns the gene CCL2 and prostate carcinoma.